Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12606515rdf:typepubmed:Citationlld:pubmed
pubmed-article:12606515lifeskim:mentionsumls-concept:C0021289lld:lifeskim
pubmed-article:12606515lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:12606515lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:12606515lifeskim:mentionsumls-concept:C0151686lld:lifeskim
pubmed-article:12606515lifeskim:mentionsumls-concept:C0694756lld:lifeskim
pubmed-article:12606515lifeskim:mentionsumls-concept:C0011847lld:lifeskim
pubmed-article:12606515lifeskim:mentionsumls-concept:C0167117lld:lifeskim
pubmed-article:12606515lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:12606515lifeskim:mentionsumls-concept:C1292733lld:lifeskim
pubmed-article:12606515pubmed:issue3lld:pubmed
pubmed-article:12606515pubmed:dateCreated2003-2-27lld:pubmed
pubmed-article:12606515pubmed:abstractTextUteroplacental insufficiency resulting in fetal growth retardation is a common complication of pregnancy and a significant cause of perinatal morbidity and mortality. Epidemiological studies show an increased incidence of type 2 diabetes in humans who were growth retarded at birth. The mechanisms by which an abnormal intrauterine milieu leads to the development of diabetes in adulthood are not known. Therefore, a rat model of uteroplacental insufficiency was developed; intrauterine growth-retarded (IUGR) rats develop diabetes with a phenotype similar to that observed in the human with type 2 diabetes. We show here that administration of a pancreatic beta-cell trophic factor, exendin-4 (Ex-4), during the prediabetic neonatal period dramatically prevents the development of diabetes in this model. This occurs because neonatal Ex-4 prevents the progressive reduction in insulin-producing beta-cell mass that is observed in IUGR rats over time. Expression of PDX, a critical regulator of pancreas development and islet differentiation, is restored to normal levels, and islet beta-cell proliferation rates are normalized by the neonatal Ex-4 treatment. These results indicate that exposure to Ex-4 in the newborn period reverses the adverse consequences of fetal programming and prevents the development of diabetes in adulthood.lld:pubmed
pubmed-article:12606515pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12606515pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12606515pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12606515pubmed:languageenglld:pubmed
pubmed-article:12606515pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12606515pubmed:citationSubsetAIMlld:pubmed
pubmed-article:12606515pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12606515pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12606515pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12606515pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12606515pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12606515pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12606515pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12606515pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12606515pubmed:statusMEDLINElld:pubmed
pubmed-article:12606515pubmed:monthMarlld:pubmed
pubmed-article:12606515pubmed:issn0012-1797lld:pubmed
pubmed-article:12606515pubmed:authorpubmed-author:SimmonsRebecc...lld:pubmed
pubmed-article:12606515pubmed:authorpubmed-author:StoffersDoris...lld:pubmed
pubmed-article:12606515pubmed:authorpubmed-author:DesaiBiva MBMlld:pubmed
pubmed-article:12606515pubmed:authorpubmed-author:DeLeonDiva...lld:pubmed
pubmed-article:12606515pubmed:issnTypePrintlld:pubmed
pubmed-article:12606515pubmed:volume52lld:pubmed
pubmed-article:12606515pubmed:ownerNLMlld:pubmed
pubmed-article:12606515pubmed:authorsCompleteYlld:pubmed
pubmed-article:12606515pubmed:pagination734-40lld:pubmed
pubmed-article:12606515pubmed:dateRevised2011-6-1lld:pubmed
pubmed-article:12606515pubmed:meshHeadingpubmed-meshheading:12606515...lld:pubmed
pubmed-article:12606515pubmed:meshHeadingpubmed-meshheading:12606515...lld:pubmed
pubmed-article:12606515pubmed:meshHeadingpubmed-meshheading:12606515...lld:pubmed
pubmed-article:12606515pubmed:meshHeadingpubmed-meshheading:12606515...lld:pubmed
pubmed-article:12606515pubmed:meshHeadingpubmed-meshheading:12606515...lld:pubmed
pubmed-article:12606515pubmed:meshHeadingpubmed-meshheading:12606515...lld:pubmed
pubmed-article:12606515pubmed:meshHeadingpubmed-meshheading:12606515...lld:pubmed
pubmed-article:12606515pubmed:meshHeadingpubmed-meshheading:12606515...lld:pubmed
pubmed-article:12606515pubmed:meshHeadingpubmed-meshheading:12606515...lld:pubmed
pubmed-article:12606515pubmed:meshHeadingpubmed-meshheading:12606515...lld:pubmed
pubmed-article:12606515pubmed:meshHeadingpubmed-meshheading:12606515...lld:pubmed
pubmed-article:12606515pubmed:meshHeadingpubmed-meshheading:12606515...lld:pubmed
pubmed-article:12606515pubmed:meshHeadingpubmed-meshheading:12606515...lld:pubmed
pubmed-article:12606515pubmed:meshHeadingpubmed-meshheading:12606515...lld:pubmed
pubmed-article:12606515pubmed:meshHeadingpubmed-meshheading:12606515...lld:pubmed
pubmed-article:12606515pubmed:meshHeadingpubmed-meshheading:12606515...lld:pubmed
pubmed-article:12606515pubmed:meshHeadingpubmed-meshheading:12606515...lld:pubmed
pubmed-article:12606515pubmed:meshHeadingpubmed-meshheading:12606515...lld:pubmed
pubmed-article:12606515pubmed:meshHeadingpubmed-meshheading:12606515...lld:pubmed
pubmed-article:12606515pubmed:meshHeadingpubmed-meshheading:12606515...lld:pubmed
pubmed-article:12606515pubmed:meshHeadingpubmed-meshheading:12606515...lld:pubmed
pubmed-article:12606515pubmed:meshHeadingpubmed-meshheading:12606515...lld:pubmed
pubmed-article:12606515pubmed:year2003lld:pubmed
pubmed-article:12606515pubmed:articleTitleNeonatal exendin-4 prevents the development of diabetes in the intrauterine growth retarded rat.lld:pubmed
pubmed-article:12606515pubmed:affiliationDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, Clinical Research Building 611B, University of Pennsylvania School of Medicine, 415 Curie Boulevard, Philadelphia, PA 19104, USA. stoffers@mail.med.upenn.edulld:pubmed
pubmed-article:12606515pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12606515pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:12606515pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:29535entrezgene:pubmedpubmed-article:12606515lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12606515lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12606515lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12606515lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12606515lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12606515lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12606515lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12606515lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12606515lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12606515lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12606515lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12606515lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12606515lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12606515lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12606515lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12606515lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12606515lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12606515lld:pubmed